Back to Search Start Over

Glucose Concentration in Regulating Induced Pluripotent Stem Cells Differentiation Toward Insulin-Producing Cells.

Authors :
Wang C
Abadpour S
Olsen PA
Wang D
Stokowiec J
Chera S
Ghila L
Ræder H
Krauss S
Aizenshtadt A
Scholz H
Source :
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2024 Jan 18; Vol. 37, pp. 11900. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).
Publication Year :
2024

Abstract

The generation of insulin-producing cells from human-induced pluripotent stem cells holds great potential for diabetes modeling and treatment. However, existing protocols typically involve incubating cells with un-physiologically high concentrations of glucose, which often fail to generate fully functional IPCs. Here, we investigated the influence of high (20 mM) versus low (5.5 mM) glucose concentrations on IPCs differentiation in three hiPSC lines. In two hiPSC lines that were unable to differentiate to IPCs sufficiently, we found that high glucose during differentiation leads to a shortage of NKX6.1+ cells that have co-expression with PDX1 due to insufficient NKX6.1 gene activation, thus further reducing differentiation efficiency. Furthermore, high glucose during differentiation weakened mitochondrial respiration ability. In the third iPSC line, which is IPC differentiation amenable, glucose concentrations did not affect the PDX1 / NKX6.1 expression and differentiation efficiency. In addition, glucose-stimulated insulin secretion was only seen in the differentiation under a high glucose condition. These IPCs have higher KATP channel activity and were linked to sufficient ABCC8 gene expression under a high glucose condition. These data suggest high glucose concentration during IPC differentiation is necessary to generate functional IPCs. However, in cell lines that were IPC differentiation unamenable, high glucose could worsen the situation.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Wang, Abadpour, Olsen, Wang, Stokowiec, Chera, Ghila, Ræder, Krauss, Aizenshtadt and Scholz.)

Details

Language :
English
ISSN :
1432-2277
Volume :
37
Database :
MEDLINE
Journal :
Transplant international : official journal of the European Society for Organ Transplantation
Publication Type :
Academic Journal
Accession number :
38304198
Full Text :
https://doi.org/10.3389/ti.2024.11900